The disclosure under the heading “Background of the Merger” is hereby amended and supplemented by replacing the ninth full paragraph on page 32 of the Proxy Statement in its entirety with the following:
PAE and Other Party A entered into a confidentiality agreement on June 14, 2021, containing customary non-disclosure and standstill provisions, and did not include a “don’t-ask-don’t-waive” provision. The standstill provisions expired on October 25, 2021.
The disclosure under the heading “Background of the Merger” is hereby amended and supplemented by replacing the tenth full paragraph on page 32 of the Proxy Statement in its entirety with the following:
In June 2021, a private equity firm (“Other Party B”) contacted PAE to discuss the possibility of evaluating a potential strategic transaction with PAE. These discussions did not progress further at this time because Other Party B was not available for negotiations.
The disclosure under the heading “Background of the Merger” is hereby amended and supplemented by replacing the second full paragraph on page 35 of the Proxy Statement in its entirety with the following:
On September 14, 2021, PAE and Other Party B entered into a confidentiality agreement, which included customary non-disclosure and standstill provisions, and did not include a “don’t-ask-don’t-waive” provision. The standstill provisions expire on September 14, 2023.
The disclosure under the heading “Background of the Merger” is hereby amended and supplemented by replacing the second full paragraph on page 36 of the Proxy Statement in its entirety with the following:
On September 24, 2021, affiliates of Parent entered into a confidentiality agreement with PAE that included customary non-disclosure and standstill provisions including a “don’t-ask-don’t-waive” provision. The standstill provisions expire on the date that is fifteen months from the date of the confidentiality agreement. Such parties also entered into a “clean team” agreement on that date, setting forth customary “clean team” procedures to facilitate the sharing of certain limited non-public, confidential and proprietary information regarding PAE.
The disclosure under the heading “Background of the Merger” is hereby amended and supplemented by replacing the fourth full paragraph on page 41 of the Proxy Statement in its entirety with the following:
Between October 25 and November 29, 2021, at the direction of the Board and in connection with the “go-shop” process, representatives of Morgan Stanley contacted 22 potential acquirers, comprising 13 potential strategic acquirers and nine potential financial acquirers, to gauge interest in such potential acquirers providing a company acquisition proposal. During the “go-shop” period, PAE executed confidentiality agreements with two potential acquirers, which included customary standstill provisions including “don’t-ask-don’t-waive” provisions, and “clean team” agreements with two potential acquirers. Since the execution of the merger agreement and during the “go-shop” period, each of the two potential acquirers received due diligence materials and one had discussions with management and representatives of Morgan Stanley regarding a potential acquisition of PAE.
The disclosure under the heading “Trading Multiples Analysis” is hereby amended and supplemented by replacing the first full paragraph on page 50 of the Proxy Statement in its entirety with the following:
For purposes of this analysis, Morgan Stanley analyzed the ratio of aggregate value (“AV”) (which Morgan Stanley defined as (i) fully diluted market capitalization, plus (ii) preferred stock, plus (iii) non-controlling interest, plus (iv) total debt, plus (v) capital leases and less (vi) cash and cash equivalents) to estimated earnings before interest, taxes, depreciation, and amortization (“EBITDA”), based on Capital IQ consensus estimates as of October 18, 2021, for calendar years 2021 and 2022, of each of these comparable companies. Operating leases were excluded from AV. Morgan Stanley’s analysis was based on a fully diluted share count using the treasury stock method (99.6 million units assuming a price of $10.05 per share), as provided by the Company.
The disclosure under the heading “Discounted Cash Flow Analysis” is hereby amended and supplemented by replacing the seventh full paragraph on page 51 of the Proxy Statement in its entirety with the following:
Morgan Stanley performed a discounted cash flow analysis, which is designed to provide an implied value of a company by calculating the present value of the estimated future cash flows and terminal value of such company. Morgan Stanley calculated a range of equity values per share of the PAE common stock based on a discounted cash flow analysis to value the Company as a stand-alone entity. Morgan Stanley utilized estimates from the Company financial projections and Company street forecast for purposes of its discontinued cash flow analysis, as more fully described below. Morgan Stanley’s analysis was based on a fully diluted share count using the treasury stock method (99.6 million units assuming a price of $10.05 per share), as provided by the Company.